Ivan Paunovic

Learn More
BACKGROUND Galectin-3 has been recently recognized as a promising presurgical marker of thyroid malignancy. METHODS Galectin-3 expression was examined immunohistochemically in 202 specimens of(More)
There remains still no clear answer as to whether or not prophylactic central compartment neck dissection (pCCND) is indicated for the treatment of patients with papillary thyroid cancer. The(More)
The aim of this study was to assess the clinical utility of circulating preoperative Cyfra 21.1 [soluble fragment of cytokeratin (CK) 19] and galectin-3 (gal-3) in patients with thyroid tumors, to(More)
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) have roles in physiological and pathological processes. We evaluated immunohistochemical expression of MMP-2 and TIMP-2 in(More)